HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
1.610
-0.040 (-2.42%)
At close: Oct 27, 2025, 4:00 PM EDT
1.640
+0.030 (1.86%)
Pre-market: Oct 28, 2025, 8:00 AM EDT
HeartBeam Market Cap
HeartBeam has a market cap or net worth of $55.24 million as of October 28, 2025. Its market cap has decreased by -4.16% in one year.
Market Cap
55.24M
Enterprise Value
50.19M
1-Year Change
-4.16%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since the IPO on November 11, 2021, HeartBeam's market cap has increased from $46.53M to $55.24M, an increase of 18.72%. That is a compound annual growth rate of 4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 55.24M | -10.95% |
| Dec 31, 2024 | 62.04M | 0.26% |
| Dec 29, 2023 | 61.87M | 58.40% |
| Dec 30, 2022 | 39.06M | 62.39% |
| Dec 31, 2021 | 24.05M | -48.30% |
| Nov 11, 2021 | 46.53M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |